Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Immunogen Inc (IMGN)  
$31.23 0.00 (0.00%) as of 4:30 Thu 2/8


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 264,900,000
Market Cap: 8.27(B)
Last Volume: 49,305,461 Avg Vol: 5,854,790
52 Week Range: $4.32 - $31.23
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  606
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   ImmunoGen is a clinical-stage biotechnology company focused on developing the antibody-drug conjugates (ADCs). Co.'s main program is mirvetuximab, an ADC targeting folate receptor alpha, a cell-surface protein overexpressed in a number of epithelial tumors, including ovarian, endometrial, and non-small-cell lung cancers. Pivekimab sunirine is an ADC comprised of an antibody designed to target CD123 with site-specific conjugation to a DNA-alkylating payload of the IGN (indolinobenzodiazepine pseudodimer) class. Co.'s pipeline program, IMGC936, is an ADC that is designed to target ADAM9, an enzyme overexpressed in a range of solid tumors and implicated in tumor progression and metastasis.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 39,348 1,060,446 4,785,085 4,785,085
Total Sell Value $1,152,494 $23,992,060 $86,338,289 $86,338,289
Total People Sold 4 5 5 5
Total Sell Transactions 4 17 26 26
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 257
  Page 4 of 11  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Enyedy Mark J CHIEF EXECUTIVE OFFICER   •       •      –    2023-08-04 4 OE $4.55 $5,901,760 D/D 1,104,218 1,545,667     -
   Enyedy Mark J CHIEF EXECUTIVE OFFICER   •       •      –    2023-08-03 4 S $16.61 $16,942,200 D/D (1,020,000) 441,449 -79%     
   Enyedy Mark J CHIEF EXECUTIVE OFFICER   •       •      –    2023-08-03 4 OE $4.55 $4,642,932 D/D 1,020,000 1,461,449     -
   Lentini Renee PRIN. FIN & ACCTG. OFF.   •       –      –    2023-08-03 4 OE $2.31 $124,907 D/D 51,033 73,876     -
   Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER   •       –      –    2023-08-02 4 S $18.12 $77,101 D/D (4,255) 10,960 -70%     
   Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER   •       –      –    2023-08-02 4 OE $4.92 $20,935 D/D 4,255 15,215     -
   Enyedy Mark J CHIEF EXECUTIVE OFFICER   •       •      –    2023-08-02 4 S $17.45 $17,371,535 D/D (995,157) 441,449 -70%     
   Enyedy Mark J CHIEF EXECUTIVE OFFICER   •       •      –    2023-08-02 4 OE $4.55 $4,527,964 D/D 995,157 1,436,606     -
   Lentini Renee PRIN. FIN & ACCTG. OFF.   •       –      –    2023-08-02 4 S $17.55 $2,602,261 D/D (148,277) 22,843 -70%     
   Lentini Renee PRIN. FIN & ACCTG. OFF.   •       –      –    2023-08-02 4 OE $2.31 $677,777 D/D 148,277 171,120     -
   Arbuckle Stuart A   –       •      –    2023-06-30 4 A $18.87 $13,115 D/D 695 4,112     -
   Thackray Helen M.   –       •      –    2023-06-30 4 A $18.87 $7,491 D/D 397 2,350     -
   Berkenblit Anna SVP & CHIEF MEDICAL OFFICER   •       –      –    2023-06-30 4 A $4.05 $13,219 D/D 3,264 113,935     -
   Wingrove Theresa SVP OF REGULATORY AFFAIRS   •       –      –    2023-06-30 4 A $4.05 $11,385 D/D 2,811 86,156     -
   Enyedy Mark J CHIEF EXECUTIVE OFFICER   •       •      –    2023-06-30 4 A $4.05 $21,226 D/D 5,241 441,449     -
   Lentini Renee V.P.-FIN., PRIN. ACCTG. OFF.   •       –      –    2023-06-30 4 A $4.05 $12,940 D/D 3,195 22,843     -
   Goldberg Mark Alan   –       •      –    2023-06-30 4 A $18.87 $16,870 D/D 894 59,088     -
   Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER   •       –      –    2023-06-30 4 A $4.05 $15,358 D/D 3,792 10,960     -
   Lentini Renee V.P.-FIN., PRIN. ACCTG. OFF.   •       –      –    2022-12-30 4 A $3.92 $5,296 D/D 1,351 19,648     -
   Wingrove Theresa SVP OF REGULATORY AFFAIRS   •       –      –    2022-12-30 4 A $3.92 $4,434 D/D 1,131 83,345     -
   Berkenblit Anna SVP & CHIEF MEDICAL OFFICER   •       –      –    2022-12-30 4 A $3.92 $1,709 D/D 436 110,671     -
   Char Daniel SVP & CHIEF LEGAL OFFICER   •       –      –    2022-11-21 3 IO $0.00 $0 D/D 0 1,000 -30%     
   Harrington-Smith Kristen SVP & CHIEF COMMERCIAL OFFICER   •       –      –    2022-11-15 4 OE $0.00 $0 D/D 25,000 25,000     -
   Wingrove Theresa SVP OF REGULATORY AFFAIRS   •       –      –    2022-06-30 4 A $3.83 $10,117 D/D 2,645 82,214     -
   Enyedy Mark J CHIEF EXECUTIVE OFFICER   •       •      –    2022-06-30 4 A $3.83 $12,783 D/D 3,342 436,208     -
  257 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 4 of 11
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us